Form 4: NEXGEL Director Steven Mark Glassman Acquires Stock Options

Director Steven Mark Glassman acquired stock options for 25,000 shares of NEXGEL, INC. common stock on September 13, 2024.

Summary

• On September 13, 2024, Steven Mark Glassman, a director of NEXGEL, INC., was granted stock options to purchase 25,000 shares of common stock.
• The exercise price of these options is $2.72 per share.
• The options vest over a period of nine months, starting with 6,250 shares vesting on September 30, 2024, and the remaining shares vesting monthly thereafter.
• The options expire on September 13, 2034.
• The grant was made pursuant to the company's 2019 Long-Term Incentive Plan, as amended, for services as a board member.
• In the event of a change in control, any unvested shares will accelerate vesting.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices. The vesting schedule and change in control provisions are generally viewed favorably.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service on the board.
• The change in control provision provides additional security and incentive for the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Stock option grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Stakeholder Impact

• The stock option grant could have a minor positive impact on shareholder sentiment.
• The grant incentivizes the director to contribute to the company's success.

Key Dates